Kwivik Therapeutics Inc Stock


Sign up today and learn more about Kwivik Therapeutics Inc Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.



Notable Investors

Silicon Valley Bank


Frisco TX, US

Total Funding


About Kwivik Therapeutics Inc Stock

Kwivik Therapeutics Inc. is a pre-IPO medtech company that has developed a way to create medical oxygen from two, dry inert powders. The oxygen is created on demand, without the need for pressurized storage. We combined this "oxygen from powder" technology with innovative biotech, engineering, IoT and AI technologies to develop a robust pipeline of products to disrupt certain respiratory, emergency medical, asthma, cluster headache/migraine, wound care and skin care markets globally, with a combined market size exceeding $750 Billion.


Funding History

October 2018$50.0M


Chief Executive Officer

Julian Ross, MBA

Chief Financial Officer

Jeff Robertson, CPA, CGMA

Chief Medical Officer

Luis Salmun, MD

Chief Information Officer

Ronald Redmer


Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: